Biofrontera Bioscience GmbH   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Leverkusen Germany (1997)

Organization Overview

First Clinical Trial
2006
NCT02799030
First Marketed Drug
2000
benzoyl peroxide (clearasil)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BIOFRONTERA | Biofrontera Bioscience GmbH